Early detection and staged treatment resolve E. coli-associated mycotic AAA with contained rupture
Background
Mycotic abdominal aortic aneurysm (AAA), especially with contained rupture, is a rare and potentially fatal condition. While most cases are attributed to common pathogens like Salmonella or Staphylococcus aureus, Escherichia coli is an uncommon causative agent. This rarity makes diagnosis challenging and highlights a gap in understanding the full spectrum of infectious etiologies for AAA. Current standard-of-care for mycotic aneurysms typically involves aggressive antibiotic therapy and surgical intervention, but the optimal timing and approach can vary based on the pathogen and patient presentation.
Study Design
A man in his early 60s presented with acute E. coli prostatitis and a prostatic abscess. During his evaluation, an abdominal ultrasound incidentally revealed a 3.8 cm infrarenal saccular AAA suspicious for contained rupture. This finding prompted further investigation with contrast-enhanced CT imaging, which confirmed focal aortic wall disruption without active extravasation. Initial treatment involved intravenous ceftriaxone and vancomycin to control the infection. After achieving infection stability, Endovascular Aneurysm Repair (EVAR) was performed using an Endurant II stent graft.
Results
The patient initially presented with acute E. coli prostatitis and a prostatic abscess, confirming an active systemic infection. An incidental abdominal ultrasound identified a 3.8 cm infrarenal saccular AAA, prompting further diagnostic imaging. CT scans provided crucial confirmation, revealing focal aortic wall disruption consistent with a contained rupture, preventing immediate, life-threatening extravasation. Intravenous ceftriaxone and vancomycin were administered, leading to observed stability on serial imaging, indicating effective infection control. This allowed for a staged approach to intervention. > Following successful infection control, Endovascular Aneurysm Repair (EVAR) with an Endurant II stent graft was performed, resulting in an uneventful recovery. The patient completed targeted antibiotic therapy, achieving a favorable outcome, demonstrating the efficacy of early detection and a coordinated multidisciplinary management strategy for this rare presentation.
Key Findings
- E. coli prostatitis led to a mycotic abdominal aortic aneurysm (AAA) with contained rupture.
- A 3.8 cm infrarenal saccular AAA was detected incidentally via abdominal ultrasound.
CTimaging confirmed focal aortic wall disruption, indicating a contained rupture.- Successful treatment involved intravenous ceftriaxone and vancomycin, followed by
EVAR. - The patient experienced an uneventful recovery, highlighting the success of early detection and a staged approach.
Why It Matters
Clinicians should maintain a high index of suspicion for rare vascular complications like mycotic AAA in patients with severe E. coli infections, even if AAA symptoms are absent. This case underscores the diagnostic value of incidental imaging findings, such as those from an abdominal ultrasound, in detecting life-threatening conditions early. The successful staged approach—prioritizing infection control with antibiotics before definitive EVAR—offers a potential protocol for managing similar complex cases where infection precedes vascular repair. This strategy could improve outcomes for patients with unusual infectious etiologies of AAA, guiding future multidisciplinary care pathways.
mycotic aneurysm
abdominal aortic aneurysm
escherichia coli
prostatitis
case report
evar